BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia

Da Costa, D., Agathanggelou, A., Perry, T. et al. (11 more authors) (2013) BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia. Blood Cancer Journal, 3 (7). e126. ISSN 2044-5385

Abstract

Metadata

Authors/Creators:
  • Da Costa, D.
  • Agathanggelou, A.
  • Perry, T.
  • Weston, V.
  • Petermann, E.
  • Zlatanou, A.
  • Oldreive, C.
  • Wei, W. ORCID logo https://orcid.org/0000-0003-1288-6999
  • Stewart, G.
  • Longman, J.
  • Smith, E.
  • Kearns, P.
  • Knapp, S.
  • Stankovic, T.
Copyright, Publisher and Additional Information: This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
Keywords: BET proteins; inhibitor; ALL
Dates:
  • Published (online): 19 July 2013
  • Accepted: 13 June 2013
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 21 Jul 2016 11:38
Last Modified: 25 Jul 2016 10:24
Published Version: http://dx.doi.org/10.1038/bcj.2013.24
Status: Published
Publisher: Nature Publishing Group
Refereed: Yes
Identification Number: https://doi.org/10.1038/bcj.2013.24
Related URLs:

Share / Export

Statistics